Breaking News

NEW YORK, Feb 12 – Celera released Monday its much-awaited material transfer agreement, which sets the terms for academic researchers wishing to download data from the company’s human genome database.

NEW YORK, Feb 12 - In a squeak barely audible under the buzz of its human genome publication announc

NEW YORK, Feb 12 – Celera released Monday its much-awaited material transfer agreement, which sets the terms for academic researchers wishing to download data from the company’s human genome database.

NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning. Shares of Celera jumped

NEW YORK, Feb 12 – News that Celera had published its human genome sequencing paper in Science and made its data available on its website helped to bolster genomics stocks Monday morning. Shares of Celera jumped 3.3, or 7.

NEW YORK, Feb 12 – Public researchers spent long hours and weekends preparing their genome sequencing paper for this week’s seminal issue of Nature . And when all was said and done, it was the mouse that took the heat. " We met on phone calls almos

NEW YORK, Feb 12 - Blackstone Technology Group said Monday that it has built a compute farm to support genomics-based research at Pfizer’s Discovery Technology Center in Cambridge, Mass. Financial terms of the deal were not disclosed. Blackstone, based i

NEW YORK, Feb 12 – Following a break of the news embargo on Sunday by The Observer of London, coverage of the human genome papers in many media outlets on Sunday and Monday offered widely disparate analyses of the papers’ significance. In

NEW YORK, Feb 12 - Blackstone Technology Group said Monday that it has built a compute farm to support genomics-based research at Pfizer’s Discovery Technology Center in Cambridge, Mass. Financial terms of the deal were not disclosed.

NEW YORK, Feb 11 - While Celera's scientists have refocused their efforts from human genome sequencing to the challenges of functional genomics, applied genomics, and proteomics, the Human Genome Project's army of scientists plans to continue sequencing the genome, a task that could take anot

NEW YORK, Feb 11 - The human genome sequencing race may be over, but as Celera and the Human Genome Project prepare to unveil their official accounts of their sequencing efforts in competing journals this week, the battle to

NEW YORK, Feb 9 - A group of academic and commercial proteomics researchers announced Friday the official launch of the Human Proteome Organization, which aims to coordinate efforts to better understand the proteome. “The object of HUPO is to try and get the human proteome projec

NEW YORK, Feb 9 - Packard BioScience said Friday it had filed a statement with the US Securities and Exchange Commission for a follow-on offering of 10 million shares.

“PRESUME you were an idiot. Now presume you were a member of Congress. But I repeat myself.” So wrote Mark Twain after trying to extend intellectual property laws to authors.

TSUKUBA, Japan, Feb 9 – Caught off guard by the recent announcement that Myriad Genetics and Syngenta had sequenced all 12 chromosomes in the rice genome, the international consortium of public rice researchers said Friday it would accelerate its effort to produce a complete sequence as quickly a

NEW YORK, Feb 9 – Celera will make its human genome sequence data available on its website on Monday and will publish its paper on the genome in Science

NEW YORK, Feb 9 – French functional proteomics company Hybrigenics signed its first commercial deal, agreeing to map the interactions of proteins associated with cancer for Servi

NEW YORK, Feb 8 – Hyseq said Wednesday its cash reserves dwindled to just $2.7 million at the end of 2000, prompting CEO George Rathmann to step in with a $20 million line of credit that could prevent the beleaguered company from going under.

NEW YORK, Feb 8 - Structural Genomix said Thursday it reached an agreement with the Cystic Fibrosis Foundation to determine the structure of a protein, cystic fibrosis transmembrane regulator, which is involved in causing cystic fibrosis.

NEW YORK, Feb 8 – Eliance Biotechnology of Dallas has gained exclusive rights to develop large-scale genetic screening technology from The Center for Biomedical Inventions at University of Texas Southwestern Medical Center, the university announced Thursday.

NEW YORK, Feb 8 – Eliance Biotechnology of Dallas has gained exclusive rights to develop large-scale genetic screening technology from the Center for Biomedical Inventions at University of Texas Southwestern Medical Center, the university announced Thursday. The technology, cal

NEW YORK, Feb 8 - Gene function discovery company Paradigm Genetics said Thursday its fourth quarter revenues shot up to $4.5 million, compared with $1.2 million, while revenues for the year increased to $10.3 million, compared with just $2.2 milli

NEW YORK, Feb 8 – An Israeli holding company said Wednesday it was launching a new subsidiary that would invest in early stage biotech companies, including genomics enterprises.

This story has been updated from a previous version. NEW YORK, Feb 8 – Bioinformatics tool provider DoubleTwist on Thursday said it added new features to its Prophecy toolkit, which includes the company's annotated human genome database and associated software.

WASHINGTON, Feb 8 – The National Institute of General Medical Sciences, a division of the NIH, is ramping up its commitment to elucidate thousands of protein structures over the next few years with a recent

Pages

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.